About
Technology
Issues
FAQ
Links
Official Page
Two years follow-up of an open-label pilot study of treatment with rituximab in patients with early diffuse cutaneous systemic sclerosis
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.